Antiseizure drug use in nursing homes before and after COVID-19
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how antiseizure medications are prescribed to long-term nursing home residents and how those prescriptions changed during the COVID-19 pandemic. It helps understand if prescribing patterns affected residents' health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must live in a nursing home for more than 100 days (long-stay resident).
- You must be 22 years or older.
- You must have continuous Medicare (fee-for-service or Advantage) and Part D drug coverage.
- You must stay in the nursing home for the full 3-month study period.
- You must be prescribed a psychoactive medication by a nursing home clinician.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to lower how often antibiotics are used in nursing home residents with Alzheimer’s disease and other dementias. It aims to make antibiotic use more appropriate while monitoring resident outcomes.
This study tests a home-based program to help people with dementia manage their medications more easily. It aims to improve safety and quality of life for patients and their caregivers.
This trial tests a new approach to help manage behavioral and psychological symptoms of dementia (BPSD) for people living in long-term care facilities. It aims to improve care and quality of life for residents with dementia.
This study tests a better way for doctors to prescribe medicines for older nursing home residents. The goal is to make sure prescriptions are safer and more tailored to each person.
This trial looks at antibiotic resistance by testing wastewater in nursing homes. It aims to understand how resistance spreads and how to better protect residents.
This study helps Veterans in VA nursing homes (Community Living Centers) safely reduce unnecessary medications, such as sedatives, to improve their health and quality of life. The program reviews medications regularly to see which ones might not be needed.
Hear when a new Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.